Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

REVERSE TRIIODOTHYRONINE (T3) - ANVISA Registration 82378830056

Access comprehensive regulatory information for REVERSE TRIIODOTHYRONINE (T3) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 82378830056 and manufactured by DIRUI INDUSTRIAL CO. LTD. The registration is held by CHINA MEHECO BRASIL COMERCIO E DISTRIBUICAO DE EQUIPAMENTOS E MATERIAIS MEDICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD., EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
82378830056
Registration Details
ANVISA Registration Number: 82378830056
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

KIT DE DETECร‡รƒO PARA TRIIODOTIRONINA REVERSA (rT3) - DIRUI
Risk Class II

Registration Details

82378830056

25351877031202305

37338619000110

Company Information

China
PT: CHINA, REPรšBLICA POPULAR

Dates and Status

Jan 15, 2024

VIGENTE

09/18/2025 19:00:01